Clinical Characteristics and Outcome in IDH1/2 Mutant AML Patients - Analysis of 3898 Newly Diagnosed Patients with Acute Myeloid Leukemia

Middeke JM, Rollig C, Kramer M, Kramer A, Bochtler T, Scholl S, Hochhaus A, Jost E, Bruemmendorf TH, Naumann R, Steffen B, Kunzmann V, Einsele H, Schaich M, Burchert A, Neubauer A, Schaefer-Eckart K, Schliemann C, Krause S, Herbst R, Haenel M, Frickhofen N, Noppeney R, Kaiser U, Baldus CD, Kaufmann M, Racil Z, Stasik S, Sockel K, Von Bonin M, Mueller-Tidow C, Platzbecker U, Berdel WE, Mayer J, Serve H, Ehninger G, Schetelig J, Thiede C, Stoelzel F (2018)


Publication Type: Conference contribution

Publication year: 2018

Journal

Publisher: AMER SOC HEMATOLOGY

City/Town: WASHINGTON

Conference Proceedings Title: BLOOD

Event location: San Diego, CA US

DOI: 10.1182/blood-2018-99-118128

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Middeke, J.M., Rollig, C., Kramer, M., Kramer, A., Bochtler, T., Scholl, S.,... Stoelzel, F. (2018). Clinical Characteristics and Outcome in IDH1/2 Mutant AML Patients - Analysis of 3898 Newly Diagnosed Patients with Acute Myeloid Leukemia. In BLOOD. San Diego, CA, US: WASHINGTON: AMER SOC HEMATOLOGY.

MLA:

Middeke, Jan Moritz, et al. "Clinical Characteristics and Outcome in IDH1/2 Mutant AML Patients - Analysis of 3898 Newly Diagnosed Patients with Acute Myeloid Leukemia." Proceedings of the 60th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA WASHINGTON: AMER SOC HEMATOLOGY, 2018.

BibTeX: Download